Recent Progress in Microencapsulation and Nanoencapsulation for Pharmaceutical Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: 20 October 2024 | Viewed by 193
Special Issue Editor
Interests: microencapsulation; nanoencapsulation; formulation development; controled drug delivery; nanotechnology; polymer based drug delivery systems; lipid based drug delivery systems
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The encapsulation of pharmaceutical ingredients in particulate and vesicular carriers on a microscale (microencapsulation) and a nanoscale (nanoencapsulation) represents one of the pillars of current drug development with clearly recognized potential for improving the quality, efficiency and safety of pharmaceutical products. The expansion of research in this area over the past half century has led to the extensive application of microencapsulation technologies in the pharmaceutical industry for both small molecules and macromolecules, thus overcoming different formulation and process challenges and achieving controlled drug release. The adaptation of microencapsulation technologies for nanoscale applications with the additional development of diverse exclusive nanotechnological platforms, as well as the progressive development of newly synthesized materials and the exploitation of excipients from renewable sources, may ensure the creation of a multitude of nanocarriers (e.g., nanoemulsions, microemulsions, polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carriers, liposomes, and superparamagnetic iron oxide nanoparticles) with specific characteristics, including stimulus-controlled release for use in target drug delivery, diagnostics, and theranostics. This Special Issue aims to highlight the current progress in the design and physicochemical characterization of micro- and nano-carriers, the assessment of their encapsulation capacity and in vitro/in vivo performances, as well as the permanently demanding aspects of formulation and process development for micro- and nano-encapsulated active ingredients.
Prof. Dr. Ljiljana Đekić
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microencapsulation
- nanoencapsulation
- small molecules
- macromolecules
- microparticles
- nanoparticles
- vesicles
- nanodispersions
- nanotechnology
- target drug delivery
- stimulus-controlled drug release
- theranostics
- formulation development
- process optimization
